Skip to content

Ultrasound-Guided Botulinum Toxin A With Different Doses in the Treatment of Childhood Hypersalivation

Ultrasound-Guided Botulinum Toxin A With Different Doses in the Treatment of Childhood Hypersalivation

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900024716
Enrollment
Unknown
Registered
2019-07-23
Start date
2019-07-23
Completion date
Unknown
Last updated
2019-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypersalivation

Interventions

Group A:Botulinum Toxin A of 60 Units
Group B:Botulinum Toxin A of 80 Units

Sponsors

Third Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
4 Years to 14 Years

Inclusion criteria

Inclusion criteria: 1) Children whose salivation accords with the teacher's salivation classification method reaching grade III-V; 2) Outpatient and hospitalized children with cerebral palsy, mental retardation and post-traumatic salivation in the Third Affiliated Hospital of Zhengzhou University; 3) Children over 4 years old; 4) After the informed consent of the patient's family members and the signing of written opinions, they were included in the study.

Exclusion criteria

Exclusion criteria: 1) Patients with systemic neuromuscular disease; 2) Applying aminoglycoside antibiotics and other drugs that interfere with neuromuscular transmission in the near future; 3) Fever or infectious disease in active stage or injection site infection; 4) Patients with masseter weakness.

Design outcomes

Primary

MeasureTime frame
teacher drooling sizing;Weighing method;The drool scale;

Countries

China

Contacts

Public ContactDengna Zhu

The Third Affiliated Hospital of Zhengzhou University

zhudengna@126.com+86 0371-66903751

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026